侧颈部淋巴结示踪技术在甲状腺癌手术治疗中的应用

doi:10.6040/j.issn.1673-3770.1.2020.042

摘要/Abstract

摘要： 目的探究纳米炭示踪技术在甲状腺癌侧颈部淋巴结评估中的价值。方法研究为前瞻性、多中心队列研究,纳入体格检查阴性、影像学怀疑侧颈部淋巴结转移的甲状腺乳头状癌患者。术中用纳米炭示踪后进行侧颈部淋巴结清扫术。根据是否炭染,将侧颈部淋巴结分区送检,统计两组淋巴结的分区以及转移情况,并根据患者的临床病理特征进行亚组分析。以颈部淋巴结清扫的结果作为金标准,计算前哨淋巴结活检的敏感度及准确率。结果 122例患者接受示踪手术,共计颈部淋巴结125例/侧。其中有侧颈部淋巴结转移117例,有中央区淋巴结转移7例,无颈部淋巴结转移1例。炭染淋巴结的中位数为6枚,其分布为Ⅳ区>Ⅲ区>Ⅱ区>Ⅴ区,分布规律与肿瘤大小、位置、腺外侵犯无关。炭染淋巴结的转移概率在各个淋巴结分区中均显著高于非炭染淋巴结(Ⅱ区:19.9%比5.6%,P<0.001;Ⅲ区:35.0%比18.3%,P<0.001;Ⅳ区:37.1%比15.2%,P<0.001;Ⅴ区:14.8%比3.7%,P<0.05)。侧颈部前哨淋巴结活检的敏感度为89.5%,准确率为91.8%。结论侧颈部淋巴结的炭染规律与甲状腺癌淋巴引流的规律基本一致,炭染淋巴结的转移概率显著高于非炭染淋巴结,是潜在侧颈部前哨淋巴结活检的示踪方法。

关键词: 甲状腺乳头状癌, 侧颈部淋巴结, 淋巴结示踪, 颈清扫, 前哨淋巴结活检

Abstract: Objective Despite the high incidence of lateral neck lymph node metastasis in papillary thyroid carcinoma(PTC), its management has remained controversial. The accuracy of ultrasound and computed tomography(CT)in lateral neck evaluation for PTC is unsatisfactory. An unnecessary neck dissection may lead to increased complications, while undetected lymph node metastasis may facilitate recurrences and necessitate resurgery. We aimed to map the draining lymph nodes in the lateral neck using carbon nanoparticles and explore its potential in neck assessment. Methods We conducted a multicenter, prospective study from August 2016 to April 2019 in PTC patients who had unpalpable lateral lymph nodes that appeared suspicious on ultrasound and/or CT. Carbon nanoparticles were injected peritumorally into the thyroid gland, and modified lateral neck dissection(compartment Ⅱ-Ⅴ)was performed. The lateral lymph nodes were classified into dyed and undyed and sent for pathological analysis. Thyroidectomy and central neck compartment dissection were performed. Results A total of 125 neck dissections were performed in 122 patients. Of the dissections, 117 were for lateral neck metastases, 7 were for central metastases, and metastasis was absent in the remaining 1. A total of 4302 lateral lymph nodes were removed, 952 of them were dyed. The median number of dyed nodes was 6 per case(range: 1-33). The distribution of dyed nodes in the neck compartments was Ⅳ> Ⅲ> Ⅱ> Ⅴ, independent of tumor size, location, or extra-thyroidal extension. The percentages of dyed lymph node metastasis in Ⅱ-Ⅴ compartments were 33.3%, 60.0%, 68.8%, and 40.0%, respectively, on a per-case basis and 10.2%, 31.4%, 27.5%, and 20.8%, respectively, on a per-node basis. Compared to undyed nodes, the risk of metastasis in dyed nodes was significantly higher in all neck compartments(compartment Ⅱ: 19.9% vs. 5.6%, P<0.001; compartment Ⅲ 35.0% vs. 18.3%, P<0.001; compartment Ⅳ: 37.1% vs. 15.2%, P<0.001; compartment Ⅴ: 14.8% vs 3.7%, P<0.05). A lateral sentinel lymph node biopsy was performed in 51 patients. The sensitivity of the lateral neck sentinel lymph node biopsy was 89.5%, the false-negative rate was 26.7%, and the overall accuracy rate was 91.8%. Conclusion Using carbon nanoparticles, we successively mapped the lateral neck lymph nodes. We found that dyed nodes had a significantly higher risk of metastasis than that of undyed nodes. This method may be useful for lateral neck sentinel lymph node biopsies in PTC.

Key words: Papillary thyroid carcinoma, Lateral cervical lymph node, Lymph node mapping, Neck dissection, Sentinel lymph node biopsy

中图分类号:

R736.1

黄乃思,马奔,官青,王蕴珺,魏文俊,卢忠武,杨舒雯,徐伟博,向俊,嵇庆海,王宇. 侧颈部淋巴结示踪技术在甲状腺癌手术治疗中的应用[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 69-74.

HUANG Naisi, MA Ben, GUAN Qing, WANG Yunjun, WEI Wenjun, LU Zhongwu, YANG Shuwen, XU Weibo, XIANG Jun, JI Qinghai, WANG Yu. Lateral neck lymph node mapping in thyroid cancer surgery[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 69-74.

参考文献

[1] Ito Y, Tomoda C, Uruno T, et al. Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma[J]. World J Surg, 2005, 29(7): 917-920. doi:10.1007/s00268-005-7789-x.
[2] Cracchiolo JR, Wong RJ. Management of the lateral neck in well differentiated thyroid cancer[J]. Eur J Surg Oncol,2018,44(3):332-337. doi: 10.1016/j.ejso.2017.06.004.
[3] Choi JS, Kim J, Kwak JY, et al. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT[J]. AJR Am J Roentgenol, 2009, 193(3): 871-878. doi:10.2214/AJR.09.2386.
[4] 高晓倩, 姜震, 耿琛琛, 等. 术前超声评估分化型甲状腺癌颈部淋巴结转移[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 135-139. GAO Xiaoqian, JIANG Zhen, GENG Chenchen, et al. Preoperative ultrasonography in detecting cervical lymph node metastasis in differentiated thyroid cancer[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(1): 135-139.
[5] 黄乃思, 马奔, 官青, 等. 示踪甲状腺乳头状癌侧颈淋巴结的前瞻性研究[J]. 中国肿瘤临床, 2018, 45(20): 1053-1056. HUANG Naisi, MA Ben, GUAN Qing, et al. Lateral cervical lymph node mapping in papillary thyroid carcinoma: a prospective cohort study[J]. Chinese Journal of Clinical Oncology, 2018, 45(20): 1053-1056.
[6] Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133. doi:10.1089/thy.2015.0020.
[7] Grani G, Fumarola A. Thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy[J]. J Clin Endocrinol Metab, 2014, 99(6): 1970-1982. doi:10.1210/jc.2014-1098.
[8] Pak K, Suh S, Hong H, et al. Diagnostic values of thyroglobulin measurement in fine-needle aspiration of lymph nodes in patients with thyroid cancer[J]. Endocrine, 2015, 49(1): 70-77. doi:10.1007/s12020-014-0410-z.
[9] Lee SK, Lee JH, Bae SY, et al. Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary? A randomized, controlled study[J]. Surgery, 2015, 157(3): 518-525. doi:10.1016/j.surg.2014.10.013.
[10] Zhan SH, Luo D, Ge W, et al. Clinicopathological predictors of occult lateral neck lymph node metastasis in papillary thyroid cancer: a meta-analysis[J]. Head Neck, 2019, 41(7): 2441-2449. doi:10.1002/hed.25762.
[11] Wu X, Li BL, Zheng CJ, et al. Predicting factors of lateral neck lymph node metastases in patients with papillary thyroid microcarcinoma[J]. Medicine(Baltimore), 2019, 98(27): e16386. doi:10.1097/MD.0000000000016386.
[12] Kim SY, Kim BW, Pyo JY, et al. Macrometastasis in papillary thyroid cancer patients is associated with higher recurrence in lateral neck nodes[J]. World J Surg, 2018, 42(1): 123-129. doi:10.1007/s00268-017-4158-5.
[13] Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection[J]. World J Surg, 2007, 31(11): 2085-2091. doi:10.1007/s00268-007-9224-y.
[14] Patron V, Hitier M, Bedfert C, et al. Predictive factors for lateral occult lymph node metastasis in papillary thyroid carcinoma[J]. Eur Arch Otorhinolaryngol, 2013, 270(7): 2095-2100. doi:10.1007/s00405-012-2305-z.
[15] Bohec H, Breuskin I, Hadoux J, et al. Occult contralateral lateral lymph node metastases in unilateral N1b papillary thyroid carcinoma[J]. World J Surg, 2019, 43(3): 818-823. doi:10.1007/s00268-018-4862-9.
[16] Lee YS, Shin SC, Lim YS, et al. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer[J]. Head Neck, 2014, 36(6): 887-891. doi:10.1002/hed.23391.
[17] Ma B, Wang Y, Yang SW, et al. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: a systematic review and meta-analysis[J]. Int J Surg, 2016, 28: 153-161. doi:10.1016/j.ijsu.2016.02.093.
[18] Park JH, Lee YS, Kim BW, et al. Skip lateral neck node metastases in papillary thyroid carcinoma[J]. World J Surg, 2012, 36(4): 743-747. doi:10.1007/s00268-012-1476-5.
[19] Attard A, Paladino NC, Lo Monte AI, et al. Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review[J]. BMC Surg, 2019, 18(Suppl 1): 112. doi:10.1186/s12893-018-0435-y.
[20] Zhao HQ, Huang T, Li HH. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer[J]. Surgery, 2019, 166(1): 55-60. doi:10.1016/j.surg.2019.01.025.
[21] Ito Y, Kudo T, Takamura Y, et al. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection[J]. World J Surg, 2012, 36(3): 593-597. doi:10.1007/s00268-011-1391-1.
[22] Baek SK, Jung KY, Kang SM, et al. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma[J]. Thyroid, 2010, 20(2): 147-152. doi:10.1089/thy.2008.0243.
[23] Lombardi D, Paderno A, Giordano D, et al. Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis[J]. Head Neck, 2018, 40(2): 242-250. doi:10.1002/hed.24936.
[24] Lee SH, Roh JL, Gong G, et al. Risk factors for recurrence after treatment of N1b papillary thyroid carcinoma[J]. Ann Surg, 2019, 269(5): 966-971. doi:10.1097/SLA.0000000000002710.
[25] Kouvaraki MA, Lee JE, Shapiro SE, et al. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma[J]. Surgery, 2004, 136(6): 1183-1191. doi:10.1016/j.surg.2004.06.045.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed